■2019年,中国约3.3亿人受到心血管疾病的影响,1,140万例特别归因于冠状动脉疾病(CAD)。一份国家公共卫生报告显示,2019年CAD的死亡率为每10万人121.59至130.14。CAD的治疗包括改变生活方式,药物,经皮冠状动脉介入治疗(PCI)和冠状动脉旁路移植术。
■目的研究数字健康计划在经皮冠状动脉介入治疗(PCI)后冠心病(CAD)患者中的管理效果。
■这项回顾性研究比较了血压,血糖,低密度脂蛋白胆固醇(LDL-C),药物依从性,改变生活方式,数字健康用户与PCI后CAD患者传统随访之间的再入院率。
■在这项对698名冠心病患者的研究中,所有患者的6个月再入院率为27.4%,数字健康用户的比率低于传统随访中的数字健康用户(22.6%与32.1%,p=0.005)。数字健康用户在血压方面的目标完成率明显更高(79.7%vs.54.7%,p<0.001),血糖(98.9%vs.82.5%,p<0.001)和LDL-C水平(71.3%vs.52.7%,p<0.001)在PCI术后6个月。数字健康小组有更多的患者采用生活方式改变,包括戒烟,保持健康的饮食,定期锻炼。在风险因素分析中,数字健康利用(OR=0.60,95CI:0.40-0.90,p=0.014)和多支血管疾病(双:OR=1.72,95CI:1.09-2.72,p=0.02;三:OR=2.59,95CI:1.61-4.17,p<0.001)是CAD相关心血管再入院的独立预测因子.
■使用数字健康平台的PCI后患者血压改善,葡萄糖,和LDL-C控制,更大的治疗依从性,增强生活方式的改变,与传统随访相比,六个月的再入院率降低。
UNASSIGNED: In 2019, approximately 330 million individuals in China were affected by cardiovascular diseases, with 11.4 million cases specifically attributed to coronary artery disease (CAD). A national public health report indicated that the mortality rate for CAD ranged from 121.59 to 130.14 per 100,000 individuals in 2019. The treatments for CAD include lifestyle changes, medications, percutaneous coronary intervention (PCI) and coronary artery bypass grafting.
UNASSIGNED: To investigate the management effect of a digital health program in patients with coronary artery disease (CAD) after percutaneous coronary intervention (PCI).
UNASSIGNED: This retrospective
study compares blood pressure, blood glucose, low-density lipoprotein cholesterol (LDL-C), medication adherence, lifestyle modification, and readmission rate between digital health users and traditional follow-up in post-PCI CAD patients.
UNASSIGNED: In this
study of 698 CAD patients, the 6-month readmission rate of all patients was 27.4%, with digital health users showing lower rates than those in traditional follow-up (22.6% vs. 32.1%, p= 0.005). Digital health users had significantly higher target achievements rates in blood pressure (79.7% vs. 54.7%, p< 0.001), blood glucose (98.9% vs. 82.5%, p< 0.001) and LDL-C level (71.3% vs. 52.7%, p< 0.001) at 6-month post-PCI. The digital health group had more patients adopting lifestyle changes, including quitting smoking, maintaining a healthy diet, and exercising regularly. In risk factor analysis, digital health utilization (OR = 0.60, 95%CI: 0.40-0.90, p= 0.014) and multivessel disease (double: OR = 1.72, 95%CI: 1.09-2.72, p= 0.02; triple: OR = 2.59, 95%CI: 1.61-4.17, p< 0.001) were independent predictors of CAD-related cardiovascular readmissions.
UNASSIGNED: Post-PCI patients using digital health platforms exhibited improved blood pressure, glucose, and LDL-C control, greater treatment adherence, enhanced lifestyle changes, and reduced six-month readmission rates versus those with traditional follow-up.